Early Intervention in Alzheimer's Disease: How Early is Early Enough?

Dong-Yu Fan^{1

2}, Yan-Jiang Wang^{3

4}

Affiliations

¹ Department of Neurology and Center for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, 400042, China.
² Chongqing Key Laboratory of Aging and Brain Diseases, Chongqing, 400042, China.
³ Department of Neurology and Center for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, 400042, China. yanjiang_wang@tmmu.edu.cn.
⁴ Chongqing Key Laboratory of Aging and Brain Diseases, Chongqing, 400042, China. yanjiang_wang@tmmu.edu.cn.

Review

Dong-Yu Fan et al. Neurosci Bull. 2020 Feb.

. 2020 Feb;36(2):195-197.

doi: 10.1007/s12264-019-00429-x. Epub 2019 Sep 7.

Dong-Yu Fan^{1

2}, Yan-Jiang Wang^{3

4}

¹ Department of Neurology and Center for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, 400042, China.
² Chongqing Key Laboratory of Aging and Brain Diseases, Chongqing, 400042, China.
³ Department of Neurology and Center for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, 400042, China. yanjiang_wang@tmmu.edu.cn.
⁴ Chongqing Key Laboratory of Aging and Brain Diseases, Chongqing, 400042, China. yanjiang_wang@tmmu.edu.cn.

No abstract available

Conflict of interest statement

The authors declare that they have no conflict of interests.

1. Sun BL, Li WW, Zhu C, Jin WS, Zeng F, Liu YH, et al. Clinical research on Alzheimer’s disease: progress and perspectives. Neurosci Bull. 2018;34:1111–1118. doi: 10.1007/s12264-018-0249-z. - DOI - PMC - PubMed
1. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985;82:4245–4249. doi: 10.1073/pnas.82.12.4245. - DOI - PMC - PubMed
1. Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 2016;8:595–608. doi: 10.15252/emmm.201606210. - DOI - PMC - PubMed
1. Panza F, Lozupone M, Logroscino G, Imbimbo BP. A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2019;15:73–88. doi: 10.1038/s41582-018-0116-6. - DOI - PubMed
1. Egan MF, Kost J, Voss T, Mukai Y, Aisen PS, Cummings JL, et al. Randomized trial of verubecestat for prodromal Alzheimer’s disease. N Engl J Med. 2019;380:1408–1420. doi: 10.1056/NEJMoa1812840. - DOI - PMC - PubMed